These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18001382)

  • 1. Vitamin K prescribing patterns and bone health surveillance in UK children with cystic fibrosis.
    Urquhart DS; Fitzpatrick M; Cope J; Jaffe A
    J Hum Nutr Diet; 2007 Dec; 20(6):605-10. PubMed ID: 18001382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and management of bone health in children with epilepsy on long-term antiepileptic drugs: United Kingdom survey of paediatric neurologists.
    Fong CY; Mallick AA; Burren CP; Patel JS
    Eur J Paediatr Neurol; 2011 Sep; 15(5):417-23. PubMed ID: 21571560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of osteoporosis in adults with cystic fibrosis.
    Hecker TM; Aris RM
    Drugs; 2004; 64(2):133-47. PubMed ID: 14717616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of nutrition practices for patients with cystic fibrosis.
    O'Brien CE; Harden H; Com G
    Nutr Clin Pract; 2013 Apr; 28(2):237-41. PubMed ID: 23223377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine use of daily oral vitamin K to treat infants with cystic fibrosis.
    Cottam ST; Connett GJ
    Paediatr Respir Rev; 2015 Oct; 16 Suppl 1():22-4. PubMed ID: 26410287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health and disease in cystic fibrosis.
    Marquette M; Haworth CS
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():2-5. PubMed ID: 27461283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on cystic fibrosis-related bone disease: a special focus on children.
    Sermet-Gaudelus I; Castanet M; Retsch-Bogart G; Aris RM
    Paediatr Respir Rev; 2009 Sep; 10(3):134-42. PubMed ID: 19651384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K supplementation in cystic fibrosis.
    van Hoorn JH; Hendriks JJ; Vermeer C; Forget PP
    Arch Dis Child; 2003 Nov; 88(11):974-5. PubMed ID: 14612359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is significant cystic fibrosis-related liver disease a risk factor in the development of bone mineralization abnormalities?
    Alex G; Catto-Smith AG; Ditchfield M; Roseby R; Robinson PJ; Cameron FJ; Oliver MR
    Pediatr Pulmonol; 2006 Apr; 41(4):338-44. PubMed ID: 16477657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bone disease in cystic fibrosis.
    Aris R; Lester G; Ontjes D
    Curr Opin Pulm Med; 2004 Nov; 10(6):524-30. PubMed ID: 15510061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K and the management of patients with cystic fibrosis.
    Durie PR
    CMAJ; 1994 Oct; 151(7):933-6. PubMed ID: 7922929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease.
    Donovan DS; Papadopoulos A; Staron RB; Addesso V; Schulman L; McGregor C; Cosman F; Lindsay RL; Shane E
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1892-9. PubMed ID: 9620924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis bone disease treatment: Current knowledge and future directions.
    Putman MS; Anabtawi A; Le T; Tangpricha V; Sermet-Gaudelus I
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S56-S65. PubMed ID: 31679730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cystic fibrosis on bone health.
    Haworth CS
    Curr Opin Pulm Med; 2010 Nov; 16(6):616-22. PubMed ID: 20739891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis.
    Engelen MP; Com G; Deutz NE
    Clin Nutr; 2014 Dec; 33(6):1117-21. PubMed ID: 24423745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women.
    Volpe SL; Leung MM; Giordano H
    Nutr Res; 2008 Sep; 28(9):577-82. PubMed ID: 19083462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Expression in Cystic Fibrosis Related Bone Disease. An Observational, Transversal, Cross-Sectional Study.
    Ciuca IM; Pop LL; Rogobete AF; Onet DI; Guta-Almajan B; Popa Z; Horhat FG
    Clin Lab; 2016 Sep; 62(9):1725-1730. PubMed ID: 28164596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches to the nutritional management of cystic fibrosis in Australia.
    Anthony H; Catto-Smith A; Phelan P; Paxton S
    J Paediatr Child Health; 1998 Apr; 34(2):170-4. PubMed ID: 9588643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations for the management of bone demineralization in cystic fibrosis].
    Sermet-Gaudelus I; Nove-Josserand R; Loeille GA; Dacremont G; Souberbielle JC; Fritsch J; Laurans M; Moulin P; Cortet B; Salles JP; Ginies JL; Guillot M; Perez-Martin S; Ruiz JC; Montagne V; Cohen-Solal M; Cormier C; Garabédian M; Mallet E;
    Arch Pediatr; 2008 Mar; 15(3):301-12. PubMed ID: 18325750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feeding practices and nutrition recommendations for infants with cystic fibrosis.
    Cannella PC; Bowser EK; Guyer LK; Borum PR
    J Am Diet Assoc; 1993 Mar; 93(3):297-300. PubMed ID: 8440827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.